MTOR and gastric adenocarcinoma: Recent study demonstrated the ability of metformin to trigger an autophagy by the AMP-activated protein kinase (AMPK) activation mechanism with the subsequent inhibition of mammalian target of rapamycin (mTOR), that is one of major inhibitor of the autophagic flux, as it was shown on human gastric adenocarcinoma cells [30].